Data Foundry

Drug recalls 2023

Montelukast Sodium Tablets — Class II drug recall D-0086-2024

Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2023-11-15, distributed nationwide. Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets

Recall numberD-0086-2024
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmDr. Reddy's Laboratories, Inc., Princeton, NJ, United States
Recall initiated2023-10-13
Classified2023-11-03
Reported by FDA2023-11-15
Terminated2024-09-09
DistributedNationwide (US)
Quantity1,656 bottles
NDC55111-0593, 55111-0593-05, 55111-0593-30, 55111-0593-78, 55111-0593-79, 55111-0593-90, 55111-0594, 55111-0594-05, 55111-0594-30, 55111-0594-78, 55111-0594-79, 55111-0594-90, 55111-0725, 55111-0725-01, 55111-0725-10, 55111-0725-30, 55111-0725-78, 55111-0725-79, 55111-0725-90
Lot numbersC2305569
Expiration dates2026-03-31

Product

Montelukast Sodium Tablets, USP 10 mg, Rx Only, 1000 count bottle, Distributed by: Dr. Reddy's Laboratories., Princeton, NJ 08540, Made in India, NDC# 55111-725-10.

Reason for recall

Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25 mg.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0086-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.